Tuesday, January 20, 2015

The Backdoor to JP Morgan: Symposia and Presentations On Line.

Every winter, the annual JP Morgan life sciences conference brings Wall Street and the U.S. pharma, biotech, and medtech community to San Francisco for four hectic days.   Admission to the actual conference - which locks down the St Francis Hotel at Union Square - is very strictly controlled.   The conference is for Wall Street and for CEOs/CFOs.

However, under SEC open information laws, most of the conferences stream online, just like quarterly earnings calls.  This isn't much advertised, but it's a public website and this is the link for the 33rd annual conference:

(Registration is free with your email).

There were four keynote events in addition to the dozens of corporate presentations.  Francis Collins, the head of NIH, gave his outlook for genomics and biotech.   There were also three panels featuring national thought leaders on the topics of pricing and value-based genomic tests, next-generation sequencing, and disruptive DHealth technologies.   More details after the break.

Diagnostic & Laboratory Testing Washington Outlook - 
Is Value-Based Reimbursement Here At Last?

Ed Pezalla, MD, MPH, VP, National Medical Director for Pharmacy Policy & Strategy, Aetna • Chandra Branham, VP, Payment & Health Care Delivery Policy, The Advanced Medical Technology Association (AdvaMed) • Scott McGoohan, J.D, Vice President, Reimbursement and Scientific Affairs, American Clinical Laboratory Association • Dan Todd, Principal, Todd Strategies
Moderators: Tycho Peterson, Senior Equity Research Analyst, J.P. Morgan • Ipsita Smolinski, Senior Analyst, Capitol Street

Harnessing the Power of Next Gen Sequencing - 
The View from the Industry

Chad Robins, CEO, Adaptive Biotechnologies Corp. • Randy Scott, Chairman and CEO, InVitae • George Yancopoulos, President, Regeneron Laboratories & Chief Scientific Officer • John Stuelpnagel, DVM, 10X Genomics 
Moderator: Tycho Peterson, Senior Equity Research Analyst, J.P. Morgan

Technology Led Disruption in Healthcare - 
A discussion with leading digital health companies on the future of healthcare

Dan Burton, CEO, Health Catalyst • Sean Duffy, Co-Founder & CEO, Omada Health • Adam Jackson, CEO, Doctor on Demand • Jeff Tangney, CEO, Doximity, Inc. • Nat Turner, Co-Founder and CEO, Flatiron 
Moderator: Bryan Roberts, Partner, Venrock Assocs

For more detail on the panel content, see here.